EUKARYOTIC CELL, July 2011, p. 985â€“997                                                                                           Vol. 10,  7
1535-9778/11/$12.00 doi:10.1128/EC.05025-11
Copyright Â© 2011, American Society Microbiology. Rights Reserved.



    Characterization, Localization, Essentiality, High-Resolution
     Crystal Structure Glucosamine 6-Phosphate N-Acetyltransferase
                        Trypanosoma bruceiäŒ¤â€¡Â§
                            Ëœo,1â€  M. Lucia Sampaio Gu
                 Karina Marin                       Â¨ther,1 Amy K. Wernimont,2 Wei Qiu,2
                                Raymond Hui, Michael  J. Ferguson1*
                                             2

      Division Biological Chemistry Drug Discovery, College Life Sciences, University Dundee, Dundee DD1 5EH,
                United Kingdom,1 Structural Genomics Consortium, University Toronto, MaRS South Tower,
                                 7th Floor, 101 College St., Toronto, Ontario, Canada M5G 1L72
                                               Received 7 March 2011/Accepted 25 April 2011

             gene predicted encode Trypanosoma brucei glucosamine 6-phosphate N-acetyltransferase (TbGNA1; EC
          2.3.1.4) cloned expressed Escherichia coli. recombinant protein enzymatically active,           high-resolution crystal structure obtained 1.86 Ã…. Endogenous TbGNA1 protein localized           peroxisome-like microbody, glycosome. bloodstream-form T. brucei GNA1 conditional null mutant           constructed shown unable sustain growth vitro nonpermissive conditions, demonstrating
          metabolic nutritional routes UDP-GlcNAc GlcNAc-6-phosphate. Analysis
          protein glycosylation phenotype TbGNA1 mutant nonpermissive conditions revealed           poly-N-acetyllactosamine structures greatly reduced parasite glycosylation profile           principal parasite surface coat component, variant surface glycoprotein (VSG), modified.           significance results potential TbGNA1 novel drug target African sleeping sickness           discussed.


   African trypanosomes protozoan parasites                      include ESAG6/ESAG7 heterodimeric transferrin recep-
cause human sleeping sickness nagana cattle,                   tor (45), major lysosomal glycoprotein p67 (1, 38), fatal diseases untreated. current                   Trypanosoma brucei membrane-bound histidine acid phospha-
drugs highly toxic; example, melarsoprol, line              tase MBAP1 (TbMBAP1) (13). molecules contain
drug sleeping sickness central nervous involve-               mannose, galactose, N-acetylglucosamine (GlcNAc) resi-
ment, kills 5  patients difficult administer.               dues. GlcNAc sugar present N-acetylchitobiosyl exception eflornithine, unsuccessful anticancer drug                cores glycoprotein N-linked glycans; glucosamine registered treatment human African trypano-                   (GlcN), derived GlcNAc N-acetylation (11), somiasis 1990, new drug registered clinical                present protein-linked free GPI structures. N-Acetyl-
use 50 years.                                                         glucosamine N-acetyllactosamine (LacNAc)
   mammalian bloodstream form (BSF) parasite,                   units Galâ?¤(1-4)GlcNAc decorate conventional complex dense coat 5 â«» 106 glycosylphosphatidylinositol (GPI)-                   N-linked glycans (28) appear unusual giant poly-
anchored variant surface glycoprotein (VSG) homodimers                        LacNAc-containing N-linked glycans flagellar
decorates plasma membrane. parasite survives                      pocket endosomal/lysosomal bloodstream
immune attack vertebrate host antigenic varia-                  form parasite (3). LacNAc repeats lacto-N-biose
tion, process involves replacement VSG coat                  repeats Galâ?¤(1-3)GlcNAc appear chains composed antigenically different VSG molecules                     procyclin GPI anchor free GPIs procyclic form (7). addition VSG, parasite expresses number                 organism (35, 42, 48). abundant glycoproteins, specific                    Sugar nucleotides used glycosyltransferases donor essential infectious bloodstream form. Examples                   substrates glycosylation reactions (15). synthesized
                                                                              cytoplasm used transported                                                                               specific transporters lumen Golgi apparatus
   * Corresponding author. Mailing address: Division Biological             endoplasmic reticulum [ER]). Sugar nucleotides Chemistry Drug Discovery, College Life Sciences, University         formed novo pathway salvage pathways, Dundee, Dundee DD1 5EH, United Kingdom. Phone: 44 (0)1382384219.              involving activation sugar using kinase Fax: 44 (0)1382348896. E-mail: m j.ferguson@dundee.ac.uk.
   â€  Present address: Dublin-Oxford Glycobiology Group, National           pyrophosphorylase. source GlcNAc eukaryotic gly-
stitute Bioprocessing Training (NIBRT), UCD Conway Insti-              coconjugates sugar nucleotide UDP-GlcNAc. se-
tute, University College Dublin, Dublin, Ireland.                             quence reactions eukaryotic novo pathway    â€¡ Supplemental material article http://ec         represented Fig. 1, starting fructose-6-phosphate (F-
.asm.org/.
   äŒ¤
     Published ahead print 29 April 2011.
                                                                              6P). alternative salvage routes exist. case,
   Â§ authors paid fee allow immediate free access            GlcN GlcNAc taken cell medium  article.                                                                 degradation oligosaccharide moieties) phosphory-

                                                                        985
 986           Ëœ O ET AL.
          MARIN                                                                                                                                   EUKARYOT. CELL

                                                                                    GCCTCGAGCTACAAATCCAGCCTCATTTGTCT-3â¬˜. products                                                                                     separate PCRs cloned BamHI/XhoI site pGEX 6P-1 (GE
                                                                                    Healthcare), representative clone PCR sequenced                                                                                     directions. TbGNA1 ORF sequence deposited EMBL
                                                                                    nucleotide sequence database (accession number FR715998). Oligonucleotides
                                                                                    obtained University Dundee oligonucleotide facility. plas-
                                                                                    mids verified sequencing (DNA Sequencing Service, College Life
                                                                                    Sciences, University Dundee).
                                                                                       Reverse transcription-PCR (RT-PCR). RNA extracted using RNeasy ex-
                                                                                    traction kits column DNase digestion (RNase-free DNase; Qiagen).
                                                                                    RNA samples, 50 ng, treated Omniscript reverse transcriptase (Qia-
                                                                                    gen) generate cDNA. cDNAs amplified PCR using Taq
                                                                                    polymerase TbGNA1 ORF primers (forward, 5â¬˜-ATGACCGATATAGTG
                                                                                    GACCTGGA-3â¬˜; reverse, 5â¬˜-CTACAAATCCAGCCTCATTTGTCT-3â¬˜)    FIG. 1. UDP-GlcNAc biosynthetic pathway eukaryotes. Abbre-                    Dol-P-Man synthetase (DPMS) primers (forward, 5â¬˜-AATGGATGCGGACCT
viations: GFA1, glucosamine 6-phosphate synthetase (EC 2.6.1.16);                   TCAGCACCCAC-3â¬˜; reverse, 5â¬˜-TAGAACCGTGAGCGCGGTGCCATAC-
PAGM, phosphoacetylglucosamine mutase (EC 5.4.2.3).                                 3â¬˜) constitutively expressed positive control.
                                                                                       Southern blotting. Genomic DNA prepared 1 â«» 108 2 â«» 108 cells
                                                                                    using DNAzol (Helena Biosciences). hygromycin phosphotransferase resis-
                                                                                    tance gene (HYG), puromycin acetyltransferase resistance gene (PAC),
lated (19) generate GlcN-6-phosphate (GlcN-6P)                               TbGNA1, TbGNA1 5â¬˜ untranslated region (UTR) probes amplified,
GlcNAc-6-phosphate (GlcNAc-6P), respectively,                         purified, 32P labeled Amersham Rediprime II random prime labeling
                                                                                    (GE Healthcare), used probe diverse digests 3 â?®g T.
feeds biosynthetic pathway. salvage pathway                                                                                     brucei genomic DNA.
confirmed biosynthetic radiolabeling T. brucei glycopro-                         Construction TbGNA1 conditional null mutant (TbGNA1cKO). gene
teins [3H]GlcN (14), presumably action hexoki-                      replacement cassettes generated PCR amplification 500 bp UTR
nase (GlcN 3 GlcN-6P). T. brucei unable interconvert                       immediately flanking 5â¬˜ 3â¬˜ ends TbGNA1 ORF Platinum Taq
UDP-GalNAc UDP-GlcNAc (42), second salvage route,                            High Fidelity DNA polymerase (Invitrogen) using forward primers 5â¬˜-CGTTG
                                                                                    TCGACCATTTGGTCAAGGTGCTGGT-3â¬˜ (SalI site, boldface) 5â¬˜-GTTT
starting galactosamine (GalN), discounted (Fig.                         AAACTTACGGACCGTCAAGCTTTGTATAGCTTCACAACTTTCG-3â¬˜ 1). novo pathway glucose probably                           reverse primers 5â¬˜-gacggtccgtaagtttaaacGGATCCttttttttgtctgcattttcgat-3â¬˜ important vivo, T. brucei does GlcNAc (4)                      5â¬˜-ATAAGTAAGCGGCCGCTAGCATACAGCACCTGTTAC-3â¬˜ (NotI site, free GlcN abundant sugar mammals                         boldface). PCR products used separate PCR produce
                                                                                    construct containing 5â¬˜ UTR linked 3â¬˜ UTR short HindIII, PmeI
insects.
                                                                                    (italics), BamHI (capital letters) cloning site. resulting DNA fragment
   biosynthesis sugar nucleotides                           ligated pGEM-5Zf(â«¹) vector (Promega) using SalI/NotI sites.
shown essential survival infectivity                       Antibiotic resistance markers cloned HindIII/BamHI restriction
trypanosomatid parasites.  UDP-galactose essential                       sites UTRs produce constructs, containing PAC bloodstream procyclic forms T. brucei ap-                         containing HYG. generate tetracycline-inducible ectopic copy                                                                                     TbGNA1 ORF, primers 5â¬˜-GTTTAAACTTACGGACCGTCAAGCTTATG
pears essential T. cruzi (25, 42, 43), GDP-mannose                      ACCGATATAGTGGACCTGGA-3â¬˜ 5â¬˜-CGCGGATCCCTACAAATCCA
essential infectivity Leishmania major survival T.                    GCCTCATTTGTCT-3â¬˜ used PCR amplify ORF, cloned
brucei (9, 10), UDP-GlcNAc essential L. major                            vector pLew100 using HindIII BamHI sites, respectively (italics).
pathogenesis mammalian host (34) growth                          constructs purified using Qiagen Maxiprep kit, double digested
                                                                                    SalI/NotI linearize DNA, precipitated, washed twice 70  eth-
survival bloodstream-form T. brucei (46).
                                                                                    anol, redissolved sterile water. linearized DNA electroporated
   glucosamine 6-phosphate N-acetyltransferase (GNA1)                           T. brucei bloodstream cells (strain 427, variant 221) stably trans-
enzymes (EC 2.3.1.4; Fig. 1) catalyze acetylation                            formed express T7 RNA polymerase tetracycline repressor protein
GlcN-6P using cofactor acetyl coenzyme (acetyl-CoA)                           G418 selection. cell line referred â€œwild typeâ€? characterized eukaryotes, including                         Cell culture, transformation, selection carried previously
                                                                                    described (55).
Mus musculus Saccharomyces cerevisiae (5, 32). crystal
                                                                                       Protein expression purification. Expression performed using Esche-
structures S. cerevisiae, Aspergillus fumigatus, human                   richia coli ArcticExpress RP(DE3) cells (Stratagene) transformed enzymes solved (20, 39, 53). GNA1                           pGEX 6P-1 vector containing TbGNA1 ORF. cells grown 30Â°C
considered potential antifungal drug target Candida                         optical density reached 1.2, isopropyl â?¤-D-1-thiogalactopy-
albicans GNA1 mutants reduced virulence mice (31).                          ranoside (IPTG) added final concentration 0.025 mM. cell
                                                                                    culture grown 48 h 12Â°C. Cells harvested; washed 50 mM  present biochemical structural properties, sub-                        Tris-HCl, pH 7.5â€“0.25 M NaCl (buffer , 1 mg/ml lysozyme, complete
cellular localization, drug target genetic validation T.                     protease inhibitor cocktail tablets (Roche); lysed French press. brucei GNA1 (TbGNA1).                                                               lysate cleared centrifugation (20,000 â«» g, 30 min, 4Â°C), superna-
                                                                                    tant containing N-terminally glutathione S-transferase (GST)-tagged TbGNA1
                                                                                    protein incubated 4Â°C 2 h glutathione-Sepharose 4B beads (GE
                        MATERIALS METHODS
                                                                                    Healthcare) previously equilibrated buffer  washing buffer 
   Parasite culture. Strain 427, variant MITat1.2  known variant 221), T.   GST tag cleaved situ using PreScission protease  kind gift Daan
brucei bloodstream-form parasites express T7 polymerase tetracycline       Van Aalten, University Dundee) buffer 1 mM dithiothreitol (DTT)
repressor protein G418 selection cultured HMI-9 medium (55)        16 h 4Â°C. sample purified gel filtration using Superdex density â¬ƒ2 â«» 106 cells/ml 37Â°C 5  CO2.                              200 HR30 high-performance liquid chromatography (HPLC) column (Amer-
   Cloning sequencing TbGNA1. putative TbGNA1 open reading               sham Biosciences). Proteins eluted 0.5 ml/min buffer monitored
frame (ORF) identified T. brucei genome database (GeneDB accession           measurement absorbance 280 nm. Fractions (2 ml) collected,
number Tb11.01.2886) amplified PCR genomic DNA Platinum            presence TbGNA1 peak fractions verified SDS-PAGE. Taq High Fidelity DNA polymerase (Invitrogen) using forward primer            protein concentrated using Vivaspin concentrator (Viva-
taining BamHI site (underlined), 5â¬˜-CGCGGATCCATGACCGATATAGTG                      science) 3,500-kDa-molecular-mass cutoff 4Â°C. TbGNA1 stored GACCTGGA-3â¬˜, reverse primer containing XhoI site (boldface), 5â¬˜-C          â«º80  buffer 10  glycerol. raising antibodies  , GST-
 VOL. 10, 2011                                                      T. BRUCEI GLUCOSAMINE 6-PHOSPHATE N-ACETYLTRANSFERASE                                                     987

TbGNA1 eluted glutathione-Sepharose 4B beads buffer                         TABLE 1. Crystallographic parameters TbGNA1a
containing 10 mM glutathione. Recombinant protein identity performed                                                                                                      Parameter                                            Value(s) TbGNA1b Proteomics Mass Spectrometry Facility, College Life Sciences, Uni-
versity Dundee.                                                                    Data collection statistics
   Recombinant TbGNA1 (1 mg/ml buffer  analyzed sedimentation              Space group ...................................................P212121
velocity centrifugation using Beckman Optima XL-1 analytical ultracentrifuge         Unit cell dimensions AN50-Ti rotor 32,000 rpm 20Â°C. Absorbance data (72 scans 280             (Ã…) ...........................................................50.86
nm) collected analyzed using SEDFIT program (44). TbGNA1                 b (Ã…) ...........................................................64.44
assumed globular, density predicted amino acid                 c (Ã…) ...........................................................82.77
composition.                                                                              Alpha (Â°) ....................................................90.00
   crystallization purposes, TbGNA1 expressed resistant strain E. coli         Beta (Â°).......................................................90.00
BL21(DE3)-V2R-pRARE2 using Lex bioreactor (Harbinger Biotechnology                      Gamma (Â°) .................................................90.00 Engineering, Markham, Ontario, Canada) purified according meth-             Wavelength ....................................................1.5418
ods described previously (51). protein sample identity purity             Resolution range (Ã…) ...................................40â€“1.86
evaluated mass spectrometry SDS-PAGE.                                            unique reflections .............................23,634
   Crystallographic analysis, data processing, refinement. TbGNA1          reflections observed..........................23,625
His6 tag intact crystallized mixing 1.5 â?®l protein  concentration    Rsym .................................................................0.049 (0.237)
10.9 mg/ml buffer 10 mM HEPES, pH 7.5, 500 mM NaCl) 1.5 â?®l             â?´å†¬Iå†­ ................................................................28.94 (7.5)
reservoir solution containing 19  polyethylene glycol 3350 0.2 M ammo-             Completeness ( ) ........................................99.9 (99.9)
nium tartrate hanging-drop vapor diffusion setup 18Â°C VDX plates            Redundancy ...................................................7.0 (6.9)
(Hampton Research, Aliso Viejo, CA). Crystals appeared 2 3 days grown 80 150 â?®m 2 weeks. Crystals briefly soaked reservoir       Refinement statistics
solution supplemented 15  ethylene glycol flash frozen        Resolution range...........................................35.96â€“1.86 (1.91â€“1.86)
liquid nitrogen data collection. Single-wavelength data collected      reflections ..........................................22,408 (1,628)
FR-E Superbright rotating anode X-ray source Raxis IVâ«¹â«¹ image plate                reflections test set ........................1,217 (95)
(Rigaku, Woodlands, TX).                                                           Rwork/Rfree.......................................................0.243/0.282 (0.309/0.331)
   Diffraction data reduced scaled program XDS (22). Mo-              atoms
lecular replacement solution obtained program balbes (24) using S.           Protein........................................................2,265
cerevisiae GNA1 searching model (Protein Data Bank [PDB] accession                   Water..........................................................238
number 1I1D). Iterative cycles model building refinement carried           Mean B factor (Ã…2) ......................................20.24 using Coot refmac programs (12, 22, 33) refinement statistics          Ramachandran ( )
data TbGNA1 (PDB accession number 3I3G) listed Table 1.                    Favored ......................................................98.15
structural figures produced using PyMOL program (www.pymol.org).                 Allowed ......................................................1.85
   Glucosamine 6-phosphate N-acetyltransferase activity assay. Acetyl coenzyme            Disallowed .................................................0  GlcN-6P, coenzyme supplied Sigma. measurements performed room temperature triplicate 96 plate format (Nunc).         RMSD activity measurement, 500 â?®M GlcN-6P 500 â?®M acetyl-CoA                    Bond length (Ã…)............................................0.002
dissolved 25 mM Tris-HClâ€“150 mM NaCl, pH 7.2, total volume 50 â?®l.           Bond angle (Â°) ...............................................0.531 reactions initiated adding 50 ng TbGNA1 protein stopped                                                                                         50 â?®l solution containing 25 mM bis-Tris-propane, 250 mM NaCl, 2 mM                    PDB accession number 3I3G.
                                                                                        b
                                                                                            Values parentheses outer shell.
EDTA, 6.4 M guanidine chloride, pH 7.5. Fifty microliters dithio-bis(2-
nitrobenzoic acid) (DTNB) solution (1 mM DTNB 0.1  dimethyl sulfoxide
containing 25 mM Tris-HCl, 250 mM NaCl, 2 mM EDTA, pH 7.5) added. Reaction DTNB coenzyme  product acetylation           mounted glass slides, sealed Hydromount containing 2.5  1,4-
GlcN, generates 2-nitro-5-thiobenzoate anion, absorbance measured         diazabicyclo[2.2.2]octane, left dry dark 30 min. Microscopy 412 nm. Absorbance quantified using Spectra Max 340 PC spectrometer          performed Zeiss LSM 510 META confocal microscope.
(Molecular Devices), data analyzed Grafit (version 5) pro-             Sugar nucleotide analysis. Sugar nucleotide analysis performed 
gram. determination kinetic constants, different concentrations      scribed previously (49). Briefly, cells pelleted centrifugation, washed 1.5 mM GlcN-6P acetyl-CoA used.                                              ice-cold PBS, lysed 70  ethanol presence 20 pmol GDP-
   TbGNA1 localization. BALB/c adult mice used raise polyclonal           glucose internal standard. Sugar nucleotides extracted using EnviCarb
antibodies GST-tagged TbGNA1. 0.1 mg mouse used             columns (Supelco) analyzed using multiple-reaction-monitoring (MRM)
immunization Freundâ€™s complete adjuvant. mouse received fur-            liquid chromatography-tandem mass spectroscopy (LC-MS/MS).
ther immunizations Freundâ€™s incomplete adjuvant 2 months. Antibod-             Lectin blotting. T. brucei cells washed trypanosome dilution buffer ies affinity purified CNBr-Sepharose-immobilized TbGNA1             hypotonically lysed 300 â?®l water containing 0.1 mM 1-chloro-3-tosylamido- GST tag removed PreScission protease. similar protocol         7-amino-2-heptone (TLCK) 1 â?®g/ml leupeptin. Cell ghosts harvested
used immunize New Zealand rabbits 0.5 mg purified TbGNA1               centrifugation (13,000 â«» g 10 min), pellet resuspended protein animal. Wild-type bloodstream-form T. brucei cells grown          SDS-sample buffer containing 8 M urea. lysed extracts subjected HMI-9 medium density 1 â«» 106 cells/ml, harvested centrifugation,       electrophoresis reducing conditions 1.5 â«» 107 cell equivalents/lane resuspended trypanosome dilution buffer (0.1 M Na2HPO4, 0.01 M NaH2PO4,            NuPAGE 4 12  bis-Tris gradient (Invitrogen) using morpholinepropane-
0.025 M KCl, 0.4 M NaCl, 5 mM MgSO4, 0.1 M glucose adjusted pH 7.45           sulfonic acid (MOPS)-SDS running buffer. Proteins transferred HCl) density 4 â«» 107 cells/ml. Aliquots (15 â?®l) added 13-mm           nitrocellulose membrane normal Western blotting conditions.
coverslips, left 4Â°C 15 min, fixed 1 ml 4  paraformaldehyde             Membranes stained Ponceau S solution demonstrate equal load-
phosphate-buffered saline (PBS) 30 min, followed 5-min washes         ing; blocked 5  bovine serum albumin, 0.05  Igepal detergent (Sigma),
2 ml PBS. Cells permeabilized 0.1  Triton X-100 PBS 10 min           0.15 M NaCl 50 mM Tris-HCl, pH 7.4; incubated 0.33 â?®g/ml room temperature. Samples blocked 5  fish skin gelatin (FSG)          biotinylated tomato lectin (Vector Labs), 3 mg/ml chitin PBS containing 10  normal goat serum. coverslips incubated           hydrolysate (Vector Labs), 1:10,000-diluted ExtraAvidin-horse-
immunopurified mouse anti-TbGNA1 (0.5 â?®g/ml) rabbit anti-glyceralde-              radish peroxidase conjugate (Sigma). membranes developed hyde-3-phosphate dehydrogenase (anti-GAPDH) antiserum 1:2,000 dilution           chemiluminescent detection (ECL-plus; GE Healthcare). rabbit antienolase antiserum 1:4,000 dilution 1  FSG PBS               Purification sVSG. VSG coat trypanosomes conveniently
0.05  Triton X-100. anti-GAPDH antienolase kind gifts Paul           released soluble form (sVSG) osmotic cell lysis 37Â°C (14). Michels (Catholic University Louvain). Samples washed              used modified version procedure Cross cell lysis scribed PBS incubated 50 â?®l Alexa 594-conjugated anti-           membrane washing step 0Â°C (26). Briefly, T. brucei cultures (100 ml) mouse IgG Alexa 488-conjugated anti-rabbit IgG 1 h. Coverslips           washed trypanosome dilution buffer, resuspended 300 â?®l lysis buffer (10
 988           Ëœ O ET AL.
          MARIN                                                                                                                        EUKARYOT. CELL




   FIG. 2. Alignment GNA1 predicted amino acid sequences. sequences Homo sapiens (Hsa), Mus musculus (Mmu), Aspergillus
fumigatus (Afm), Saccharomyces cerevisiae (Sce), T. cruzi (Tcr), T. brucei, L. major (Lma) aligned using Clustal W (http://www.ebi
.ac.uk/) Jalview (http://www.jalview.org/) programs. Residues required activity (circles) involved charge distribution (triangles) highlighted. classical motifs GNA1s (motifs D) boxed, consensus motif [(R/Q)-X-X-Q-X-G] GNC5-related
N-acetyltransferase family underlined motif 



mM NaH2PO4-Na2HPO4, pH 8.0, 0.1 mM TLCK, 1 â?®g/ml leupeptin, 1                   analysis suggests TbGNA1 shares structural similarities â?®g/ml aprotinin), incubated 37Â°C 10 min. lysate cooled      members GNAT superfamily  particular, ice 2 min centrifuged 16,000 â«» g 5 min. supernatant applied 200 â?®l DE52 (Whatman) preequilibrated 10 mM NaH2PO4-
                                                                                    GNA1 orthologues (Fig. 2). closest relatives TbGNA1 Na2HPO4, pH 8.0, buffer eluted 4 times 200 â?®l fresh lysis buffer.   putative GNA1s predicted kinetoplastid genome se-
eluates pooled concentrated 100 â?®l using YM-10 spin concentrator      quences. T. cruzi contains putative genes TcGNA1 63
(Microcon), yielding 50 â?®g sVSG. majority buffer salts     62  identities T. brucei gene sequence, L.
removed diafiltration additions 0.5 ml water. procedure
                                                                                    major gene similar 44  identity. maximum
yields sVSG preparations sufficiently pure (â¬Ž90  SDS-PAGE Coomassie blue staining) analysis mass spectrometry (26, 46).                likelihood tree obtained using PhyML program (2), kineto-
   Electrospray mass spectrometry sVSG. Intact sVSG diluted 0.05          plastid GNA1 sequences separate clade (Fig. 3). Com-
â?®g/â?®l 50  methanolâ€“1  formic acid loaded Micromass type F               pared sequence human orthologue (Fig. 2), T.
nanotips. sVSG analyzed positive-ion electrospray tandem mass            brucei GNA1 shares 26  identity, spectrometry using Applied Biosystems Q-StarXL instrument (26, 46). data processed using Bayesian protein reconstruction algorithm (ABI        residues involved activity conserved.  
Analyst Software).                                                                  servative changes observed 9 amino acids described    Accession numbers. DNA sequence T. brucei GNA1 deposited         essential activity (23, 30). charge distribution EMBL nucleotide sequence database, accession number FR715998. Coor-             proposed GlcN-6P binding pocket important role dinates TbGNA1 determined X-ray crystallography deposited Protein Data Bank, accession number FR715998 1.86-Ã… resolu-
                                                                                    substrate affinity catalytic activity. consensus
tion.                                                                               motif GCN5-related N-acetyltransferases (R/Q)-XX-G-X-G
                                                                                    (52), X amino acid, conserved T. brucei
                                                                                    GNA1, corresponding R-GA-G-L-G (amino acids 94 99).
                                 RESULTS
                                                                                     low sequence similarity TbGNA1    Identification, cloning, expression TbGNA1. GNA1                       Homo sapiens GNA1 (HsaGNA1) prompted investigation amino sugar N-acetyltransferase member GCN5-                        differences extended crystal structure.
related N-acetyltransferase (GNAT) superfamily (30, 32).                             TbGNA1 ORF cloned pGEX 6P-1 expres-
BLASTp search T. brucei predicted protein database                      sion vector GST tag N terminus PreScission Saccharomyces cerevisiae GNA1 amino acid sequence (NCBI                         protease site protein tag. plasmid accession number NP_116637.1) human GNA1 (NCBI ac-                              transformed E. coli DH5â?£ cells purified described
cession number NP_932332.1) revealed putative TbGNA1 gene                         Materials Methods. Analysis untagged recombi-
(GeneDB accession number Tb11.01.2886). 444-bp TbGNA1                           nant TbGNA1 protein gel filtration analytical ultracen-
open reading frame (EMBL accession number FR715998)                             trifugation 0.5 mg/ml 0.75 mg/ml indicated amplified PCR genomic DNA prepared T. brucei                           majority TbGNA1 dimeric concentrations  strain 427. single-nucleotide difference, corre-                  Fig. S1 supplemental material).
sponding codon change, 427 sequence reported                          Crystal structure TbGNA1. TbGNA1 constructs 927 genome strain (G184 replaced C184). Sequence                      prepared order achieve crystallization; 
 VOL. 10, 2011                                            T. BRUCEI GLUCOSAMINE 6-PHOSPHATE N-ACETYLTRANSFERASE                                 989




  FIG. 3. Phylogenetic analyses glucosamine 6-phosphate N-acetyltransferases. amino acid sequences GNA1s mouse (NCBI
accession number 54342), rat (NCBI accession number 498486), bovine (NCBI accession number 512299), Homo sapiens (NCBI accession number
64841), Saccharomyces cerevisiae (NCBI accession number 850529), Aspergillus flavus (NCBI accession number 7920275), Aspergillus niger (NCBI
accession number 4986135), Aspergillus fumigatus (NCBI accession number 3505194), Danio rerio (NCBI accession number 554143), Xenopus laevis
(NCBI accession number 379524), Trypanosoma brucei (NCBI accession number 3665679), T. cruzi (NCBI accession numbers 3551278/3544900), L.
major (NCBI accession number 5653516) aligned, phylogenetic relationships analyzed using Jalview (version 2.6) (54) PhyML
(2) programs. tree rooted midpoint calculation, numbers colon correspond bootstrap support branch. branch lengths given colon calculated WAG model. Asterisks indicate putative GNA1s identified sequence homology.



struct 4 N-terminal residues successful.              respect resembles S. cerevisiae GNA1 refined structure contains homodimer, mono-                 structure (PDB accession number 1I1D). HsaGNA1 struc-
mer (named chains B crystal structure) composed                ture 35 extra residues N terminus 146 residues amino-terminal valine miss-               T. brucei gene sequence. Overall, root mean square
ing chain electron density map. Chain B includes               difference (RMSD) TbGNA1 main chains S. residues construct, including 6 residues              cerevisiae GNA1 1.41 Ã…, compared HsaGNA1
amino-terminal tag. structure resembles classic                   sequence, RMSD 1.55 Ã…, suggesting major confor-
GNAT fold (39, 52), containing motifs  D; Fig. 2)             mational differences exact secondary structure. 
conserved GNATs. Unfortunately, structure                       RMSD narrowed just C terminus natural ligands (GlcN-6P, acetyl-CoA, GlcNAc-6P,                   (residues 63 134), results S. cerevisiae GNA1 (Sce-
CoA) glucose-6-phosphate (21) obtained. Similar                 GNA1) extremely close, 0.804 Ã… compared 1.411 Ã… GNATs, including Saccharomyces cerevisiae (PDB                 humans. Aspergillus fumigatus GNA1 (AfmGNA1)
accession number 1I1D) human (PDB accession num-                    structure (PDB accession number 2VEZ) recently 
ber 2HUZ) homologues, TbGNA1 (PDB accession number                          ported (20) adopts C-terminal fold similar 3I3G) features dimeric structure created intertwining              TbGNA1. common feature, TbGNA1, AfmGNA1, C-terminal beta strands (Fig. 4B). TbGNA1 dimer                  SceGNA1 adopt long beta strand lines bot- present crystal lattice solution,         tom sugar binding pocket, human structure
demonstrated gel filtration analytical centrifugation              shows interruption, placing residues outside results  Fig. S1 supplemental material). GNAT                pocket lining, pointing away active-site entrance (Fig.
superfamily signature clearly apparent: N-terminal strand             4B, arrow).
(â?¤1), followed â?£ helices (â?£3-â?£4-â?£5), antiparallel               noted AfmGNA1 structure, acetyl-
â?¤ strands, signature central helix (â?£8), fifth â?¤ strand, â?£          CoA pocket relatively unchanged HsaGNA1 helices (â?£9 â?£10), sixth final â?¤ strand (Fig. 4A).             TbGNA1, sugar binding pocket contains signifi-
TbGNA1 adopts overall fold human orthologue                 differences. residues essential interactions shows typical intertwining C-terminal beta strands,             substrates, K118 Y117 (involved posi- maintains longer hydrogen-bonding network area                 tioning phosphate group) D87  positions  990         Ëœ O ET AL.
        MARIN                                                                                                                   EUKARYOT. CELL




   FIG. 4. Crystal structure TbGNA1.   Representation domains present TbGNA1 monomer N-terminal motif C
(red), motif D (blue), motif (violet), motif B (yellow). Light blue, second chain forms dimer. (B) Overall structure comparison TbGNA1 (cyan blue, domain dimeric structure) HsaGNA1 (gray). Arrows point C-terminal discrepancies H. sapiens T. brucei entrance sugar binding site. (C) Close HsaGNA1 active site, representing surface charge shape pocket. ribbon cartoon shows specific interactions substrates. (D) TbGNA1 active site, representing surface
charge shape pocket. (E) Ribbon cartoon sticks showing specific interactions substrates H. sapiens GNA1 structure
(green blue, corresponding different domains). (F) Ribbon cartoon sticks showing specific interactions substrates T.
brucei GNA1 structure. TbGNA1 crystallized presence substrates, figure created modeling N-acetyl-D-
glucosamine-6-phosphate human structure.



carbohydrate residue pocket), highly                deeper pocket human protein (Fig. 4D). conserved structures. spite high               narrowness TbGNA1 pocket possibly attrib-
conservation observed residues involved activity,             uted fact structure bound substrate.
significantly different environment pocket lining               SceGNA1 AfmGNA1 pockets parasite enzyme compared                       affected substrate binding, making unlikely.
HsGNA1. parasite enzyme, V82 replaces R116 I110                 Lastly, replacement H111 (Fig. 4E; conserved S. cerevi-
replaces T76, changing shape charge pocket.              siae, H. sapiens,  fumigatus involved phosphate
addition, TbGNA1 H139 creates smaller entrance                    positioning) R77 interesting, residue pocket (compared E174 HsaGNA1 A151 Sce-                        positioned pocket. longer residue possibly
GNA1), overall pocket shape narrower                    link phosphate linking water outside posi-
 VOL. 10, 2011                                          T. BRUCEI GLUCOSAMINE 6-PHOSPHATE N-ACETYLTRANSFERASE                              991




  FIG. 5. Subcellular localization TbGNA1. Wild-type bloodstream-form T. brucei cells stained affinity-purified mouse anti-
TbGNA1 Alexa 488-conjugated antimouse antibody (green channel)  E) rabbit anti-GAPDH Alexa 594-conjugated
antirabbit antibody (red channel) (B) mark glycosomes rabbit antienolase Alexa 594-conjugated anti-rabbit antibody (red channel)
(F) mark cytosol. Merged images shown (C G), corresponding phase-contrast images shown (D H).



tion, potentially crowd correct phosphate          combination following electroporation parasites positioning moved similar position histidines        presence linear DNA containing HYG flanked 500 structures (Fig. 4F).                                       bp TbGNA1 5â¬˜ 3â¬˜ UTRs. Following selection    Enzyme kinetics. address question TbGNA1               hygromycin, âŒ¬TbGNA1::HYG clone selected trans-
encodes active acetyltransferase, enzymatic assays             formed ectopic, tetracycline-inducible copy recombinant protein performed described Materials             TbGNA1 introduced ribosomal DNA (rDNA) locus Methods. Analysis kinetic data demonstrated           phleomycin selection (55). tetracycline induction,
obeyed simple Michaelis-Menten kinetics substrates              second endogenous allele replaced PAC gene linear Lineweaver-Burke plots  Fig. S2 supple-           yield desired âŒ¬TbGNA1::HYG/TbGNA1Ti/âŒ¬TbGNA1::PAC
mental material). apparent Km values GlcN-6P (144 â«¾              clone. round transformation, selected clones
11 â?®M) acetyl-CoA (234 â«¾ 44 â?®M) similar                 analyzed Southern blotting using TbGNA1 ORF probe.
reported GNA1s (23, 32). activities              blot obtained transfection (Fig. 6B) shows
combinant proteins affected presence His6             successful introduction ectopic copy replace- GST tags (data shown). Recombinant TbGNA1                  ment endogenous alleles âŒ¬TbGNA1::HYG/
stored â«º80Â°C months 10  glycerol               TbGNA1Ti/âŒ¬TbGNA1::PAC clone used studies. significant loss activity.                                            TbGNA1 conditional null mutant cell line referred    Subcellular localization TbGNA1. Mouse anti-TbGNA1                 TbGNA1cKO.
affinity-purified antibodies used rabbit anti-           TbGNA1 gene essential bloodstream-form T. brucei
GAPDH antibody glycosomal marker. secondary                  vitro. Triplicate cultures wild-type TbGNA1 condi-
tibodies antimouse Alexa 488 (red) antirabbit Alexa             tional null mutant cells inoculated permissive 594 (green). fluorescence micrographs wild-type cells             nonpermissive conditions  e., tetracycline, anti-GAPDH colocalized anti-                      respectively) 2.5 â«» 105 cells/ml subcultured day.
TbGNA1, indicating TbGNA1 located predominantly               TbGNA1 conditional null mutant cultures permis-
glycosome microbodies bloodstream-form T. brucei (Fig. 5A             sive conditions growth rates similar rate wild C). similar experiment performed rabbit anti-              type (Fig. 7A). nonpermissive conditions, cells grew
enolase antibodies cytosolic marker (Fig. 5E G),           2 days subculturing failed grow 5 days (Fig. colocalization  Additional images showing              7B).  cultures resumed growth day
cells shown Fig. S3 supplemental material.                 8. Analysis reverse transcription-PCR confirmed    Construction TbGNA1 conditional null mutant. RT-                 TbGNA1 mRNA undetectable 6 h tetracycline 
PCR primers described Materials Methods              moval cells resumed growth 10 days TbGNA1 ORF expression showed gene transcribed               tetracycline removal reexpressing TbGNA1 mRNA (Fig. procyclic bloodstream forms parasite              7C). phenomenon, conditional null mutants 
(data shown). conditional null mutant construction               come tetracycline independent, known trypanosoma-
strategy summarized Fig. 6A possible                 tids evidence gene essentiality (43).
genome assembly clearly indicates TbGNA1 present                 order check addition GlcN sufficient single copy haploid genome. Southern blot analysis               rescue GNA1 knockout, medium added GlcN (1
using TbGNA1 ORF probe consistent                   mM) used parallel cultures.  phenotype
conclusion (Fig. 6B).                                                    changed parasites died 2 days (data    TbGNA1 allele replaced homologous                 shown), showing novo pathway UDP-GlcNAc
 992        Ëœ O ET AL.
       MARIN                                                                                                     EUKARYOT. CELL




  FIG. 6. Creation bloodstream-form T. brucei TbGNA1 conditional null mutant.   Schematic representation genetic
transformations. endogenous allele TbGNA1 replaced HYG, creating âŒ¬TbGNA1::HYG. ectopic copy (pLew100-
TbGNA1) inserted rDNA region, creating âŒ¬TbGNA1::HYG/TbGNA1Ti. second allele TbGNA1 replaced PAC, creating âŒ¬TbGNA1::PAC/TbGNA1Ti/âŒ¬TbGNA1::HYG. (B) Southern blots. Genomic DNA wild-type (WT) T. brucei 427 digested BssSI, PstI, HindIII, SalI probed TbGNA1 ORF probe, showing TbGNA1 single-copy gene.
Genomic DNA TbGNA1 conditional null mutant (dKO) digested PstI BssSI probed TbGNA1 open reading
frame, confirming copy present mutants ectopic gene.


biosynthesis main source sugar nucleotide T.    TbGNA1 gene expression parasite UDP-GlcNAc levels,
brucei.                                                           sugar nucleotides extracted TbGNA1 condi-
  Phenotypic characterization TbGNA1 conditional null          tional null mutant permissive nonpermissive condi-
mutant. analyze effect selective removal         tions quantified ion-pair HPLC-electrospray ioniza-
 VOL. 10, 2011                                           T. BRUCEI GLUCOSAMINE 6-PHOSPHATE N-ACETYLTRANSFERASE                                           993




   FIG. 7. T. brucei TbGNA1 conditional null mutant: confirmation gene essentiality culture.   Growth curve TbGNA1 conditional null
mutant cells, subcultured day, grown permissive (plus tetracycline) conditions. (B) Growth curve TbGNA1 conditional null mutant
cells, subcultured day, grown nonpermissive (minus tetracycline) conditions. (C) Ethidium bromide-stained agarose gel reverse
transcription-PCR products RNA extracted TbGNA1 conditional null mutant cells 0, 6, 24, 48 h 10 days tetracycline, indicated. middle panel shows reverse transcription-PCR products using TbGNA1 primers, upper panel control reverse transcriptase, lower panel control using DPMS primers equal RNA input.

                                                                                 TABLE 2. Quantification sugar nucleotides liquid
tion-MS/MS method described previously (49). Briefly, sugar                          chromatography-tandem mass spectrometrya
nucleotides extracted T. brucei, separated HPLC,                                          Sugar nucleotide concn (pmol/107 cells)
                                                                               Sugar quantitated MRM tandem mass spectrometry using                     nucleotide        Wild type         0h             24 h             48 h
internal standard, GDP-glucose, sugar nucleotide trypanosomes. levels UDP-GlcNAc, UDP-Glc,                 UDP-glucose         182 â«¾ 15       210 â«¾ 5        281 â«¾ 50       267 â«¾ 40
UDP-Gal, GDP-Man TbGNA1 conditional null cell                  UDP-galactose        44 â«¾ 9         68 â«¾ 15         78 â«¾ 8        94 â«¾ 6
                                                                          UDP-GlcNAc          209 â«¾ 12       270 â«¾ 14       224 â«¾ 40        17 â«¾ 2
line permissive conditions agree reasonably           GDP-mannose          12 â«¾ 4         19 â«¾ 3          26 â«¾ 5        39 â«¾ 12
wild-type levels (46, 49).  dramatic reduction               GDP-fucose         0.18 â«¾ 0.03     0.2 â«¾ 0.04     0.15 â«¾ 0.07     0.1 â«¾ 0.03
UDP-GlcNAc levels, 6 , occurs 48 h tetracy-                                                                                                  Sugar nucleotides extracted TbGNA1 conditional null mutant 0,
cline removal (Table 2). cell cultures stopped divid-            24, 48 h withdrawal tetracycline. experiments performed
ing 48 72 h died, cell lysis, 72 h.        triplicate.
 994         Ëœ O ET AL.
        MARIN                                                                                                                 EUKARYOT. CELL


   Effects UDP-GlcNAc starvation protein glycosylation.         HsaGNA1, AfmGNA1, SceGNA1, TbGNA1 replaces poly-N-acetyllactosamine-specific lectin Lycopersi-          R181 D146, complete change charge function. esculentum (tomato lectin) used detection         neighboring arginine (R144; Fig. 4F) able glycoproteins flagellar pocket endosomal/lysosomal         phosphate positioning duties poking pocket T. brucei (36). tomato lectin binding oligosac-         correct position forming hydrogen bonds anom-
charide structures shown include family             alous aspartate. seen Fig. 4D, TbGNA1 unusually large N-linked poly-N-acetyllactosamine-containing          large positive patch accommodate glycans average 54 N-acetyllactosamine repeats         phosphate moiety negative patch  similar glycan (3). effect UDP-GlcNAc starvation              HsaGNA1.  size pocket created structures assessed using Western blots cell ly-         dimer actually longer narrower human 
sates wild-type TbGNA1 conditional null mutant cell          thologue, providing potentially exploitable differences lines probed tomato lectin. large smear detected        design discovery specific inhibitors. wild-type cell lysate, decreased progressively 0          GNA1 enzymes, like components hexosamine 48 h absence tetracycline TbGNA1 condi-           biosynthesis, typically cytosolic eukaryotes, mu-
tional null mutant (Fig. 8, lanes 1 4). decreased intensity    rine GNA1 association cytoplasmic tomato lectin binding high-molecular-mass glycopro-         face Golgi apparatus intracellular vesicle mem-
teins indicated significant reduction total poly-N-acetyllac-    branes (5). association based hydrophobic annexin
tosamine synthesis cellular levels UDP-GlcNAc fall.         V-like domain present mammalian GNA1s, specificity tomato lectin blot carbohydrate        absent TbGNA1. contrast, TbGNA1 localizes gly-
confirmed inhibition chitin hydrolysate (Fig. 8, lanes 5      cosomes. Glycosomes trypanosomatids belong micro- 8).                                                                body family organelles, containing glyoxysomes plants
   effects UDP-GlcNAc starvation VSG glycosyla-             peroxisomes eukaryotes. organelles resem-
tion studied. sVSG purified wild-type          ble respect morphology contain TbGNA1 conditional null mutant cells grown presence            common species-specific metabolic functions (29, 37). absence tetracycline 48 h. Analysis SDS-PAGE            unique feature trypanosomatid glycosomes essential Coomassie blue staining revealed sVSGs wild-            role carbohydrate metabolism, e., glycolysis, gluconeogen-
type TbGNA1 conditional null cells grown permis-            esis, glycerol metabolism, pentose-phosphate pathway
sive conditions appear single bands, sVSG         (18, 29). Glycosomal proteins typically targeted TbGNA1 conditional null mutant grown 48 h absence          organelles peroxisomal targeting sequence (PTS), tetracycline appeared doublet (Fig. 9A B).            located C terminus (PTS-1) N terminus
VSG doublet present mutant represents VSG molecules            (PTS-2) protein. Internal targeting sequences similar wild type  e., upper     proposed targeting mechanism, T.
band) VSG molecules selectively lost N-           cruzi phosphoglucomutase T. brucei triosephosphate
linked glycan C-terminal Asn428 site  e., lower        isomerase examples (16, 40).  proteins band), previously described T. brucei UDP-       traffic glycosome piggybacking glycosome-
GlcNAc pyrophosphorylase (TbUAP; EC 2.7.7.23) conditional             targeted proteins (47). conventional trypanosome PTSs
null mutant (46).

                         DISCUSSION
   paper, identified Tb11.01.2886 gene
encoding GNA1 activity T. brucei. organism appears typical eukaryotic UDP-GlcNAc biosynthetic path-
way (46),  dimeric nature Km TbGNA1 GlcN-6P similar human homologue.  parasite enzyme approximately 10-fold
higher Km acetyl-CoA human homologue.
TbGNA1 HsaGNA1 26  amino acid sequence
identity share GNAT motifs, like S.
cerevisiae Aspergillus, crystal structures quite sim-
ilar (20, 21, 39, 53). apo structure TbGNA1 (despite efforts obtain complexes acetyl-
CoA, CoA, GlcN-6P, GlcNAc-6P, Glc-6P), make
                                                                         FIG. 8. Phenotypic characterization TbGNA1 conditional null
useful comparisons parasite human active-site         mutant. Tomato lectin blotting wild-type TbGNA1 conditional
pockets: human GNA1 active site, GlcN6P interacts              null mutant extracts. Extracts wild type (lane 1) TbGNA1
closely R116 R181 (20); residues di-          conditional null mutant cells 0, 24, 48 h tetracycline removal
rectly contact reaction product. Similar Aspergillus       (lanes 2, 3, 4, respectively) subjected SDS-PAGE, trans-
                                                                      ferred nitrocellulose, probed biotinylated tomato lectin,
fumigatus enzyme, TbGNA1, R116 replaced V82,               followed horseradish peroxidase-streptavidin. Lanes 5 8, smaller, neutral residue, presumably reducing ability       lanes 1 4, respectively, tomato lectin inhibitor (chitin
teract phosphate group. Noticeably, contrast       hydrolysate) included lectin.
 VOL. 10, 2011                                            T. BRUCEI GLUCOSAMINE 6-PHOSPHATE N-ACETYLTRANSFERASE                                995




  FIG. 9. Electrospray mass spectrometry sVSG TbGNA1 conditional null mutant. Cells grown presence tetracycline   absence tetracycline (B) 48 h analyzed positive-ion electrospray mass spectrometry, data processed Bayesian protein
reconstruction produce mass graphs isobaric glycoforms. SDS-PAGE bands sVSG detected Coomassie blue staining. Models principal glycoforms similar observed TbUAP mutant indicated. amu, atomic mass units.
 996         Ëœ O ET AL.
        MARIN                                                                                                                   EUKARYOT. CELL

 apparent TbGNA1   T. cruzi L.      (Asn428) N-glycosylation site. similar situ-
major orthologues (37), likely TbGNA1 uses            ation described TbUAP TbALG3 mutants (26, 46), piggybacking mechanism unidentified inter-       reemphasizes relative importance N-glycosylation
nal targeting sequence. case, TbGNA1 joins list         Asn263 site Asn428 site. similar
enzymes novo sugar nucleotide biosynthesis          conclusion recently drawn conditional null mu- experimentally identified glycosomal components.         tant T. brucei GDP-Man pyrophosphorylase (10). include UDP-GlcNAc pyrophosphorylase (46),                   summary, paper extended knowl-
GDP-mannose 4,6-deydratase GDP-fucose biosynthesis               edge enzymology location hexosamine biosyn-
(50), UDP-glucose 4â¬˜-epimerase UDP-galactose biosynthe-          thesis T. brucei determined TbGNA1 es-
sis (42), UDP-glucose pyrophosphorylase UDP-glucose          sential gene bloodstream-form T. brucei  
biosynthesis (27). addition, hexokinase, necessary   potential target drugs activity pathways, phosphoglucose isomerase, necessary         parasite.  therapeutic potential obviously
GDP-mannose, GDP-fucose, UDP-GlcNAc biosynthesis,               depend ability drug-like parasite-specific known glycosomal components. Finally, phosphoman-          TbGNA1 inhibitors, enzyme generally essential nose isomerase, contains PTS1 signal necessary       eukaryotes (5, 31, 32).  inhibitors GDP-mannose GDP-fucose biosynthesis,               GNAT family members developed (17, 41, 56), glycosome proteome (6). possible       structure TbGNA1 shows similar sugar nucleotide biosynthesis machinery     dimerization mode human protein localized glycosome T. brucei rate     similar activities specificities, active sites dissim-
synthesis sugar nucleotides controlled, degree,    ilar, key residues replaced. differ-
compartmentalization. mechanism             ences exploited drug discovery process.
proposed alternative allosteric regulation gly-
colysis T. brucei (18).                                                                   ACKNOWLEDGMENTS
   construction conditional null mutant               work supported Wellcome Trust Programme Grant
TbGNA1 gene enabled test essentiality          (085622) M J.F. grateful University Dundee
confirm alternative routes GlcNAc-6P.          Proteomics Facility Mark Agacan, supported Wellcome
Essentiality expected result, TbUAP known       Strategic Award 083481, performing proteomics ultracen- essential (46).  half genes     trifugation experiments. Structural Genomics Consortium                                                                     registered charity (number 1097737) receives funds Ca-
T. brucei encode hypothetical proteins unknown function,         nadian Institutes Health Research, Canadian Foundation fewer experimentally annotated,         Innovation Genome Canada, GlaxoSmithKline, Karolinska Insti-
GNAT enzyme superfamily largest known,            tutet, Knut Alice Wallenberg Foundation, Ontario Inno-
possibility redundancy certainly excluded prior     vation Trust, Ontario Ministry Research Innovation,
                                                                    Merck, Novartis Research Foundation, Swedish Agency experimental verification. recent relevant case         Innovation Systems, Swedish Foundation Strategic Research,
point unexpected nonessentiality UDP-Glc pyrophos-        Wellcome Trust.
phorylase L. major, transpires function       grateful Alan R. Prescott (Division Cell Signaling compensated relatively nonspecific UDP-sugar            Immunology, University Dundee) valuable help micros-
pyrophosphorylase (8) present T. cruzi (57).        copy. thank Paul Michels providing anti-GAPDH                                                                     antienolase antibodies, Daan van Aalten providing vectors, Jim
   phenotype TbGNA1 conditional null mutant           Procter Geoff Barton helpful advice sequence comparisons.
der nonpermissive conditions similar TbUAP          conflicts declare.
conditional null mutant, e., rapid cessation growth death cell lysis 48 72 h tetracycline removal (Fig.                                     REFERENCES
7B).  like TbUAP mutant, took 48 h             1. Alexander, D. L., K. J. Schwartz,  E. Balber, J. D. Bangs. 2002.
                                                                        Developmentally regulated trafficking lysosomal membrane protein
UDP-GlcNAc fall 5  wild-type levels.             p67 Trypanosoma brucei. J. Cell Sci. 115:3253â€“3263. UDP-glucose UDP-galactose levels dropped            2. Anisimova, M., O. Gascuel. 2006. Approximate likelihood ratio test 60  wild-type levels 48 h TbUAP mutant,           branchs: fast, accurate powerful alternative. Syst. Biol. 55:539â€“552.
                                                                     3. Atrih, , J. M. Richardson,  R. Prescott, M.  Ferguson. 2005. levels sugar nucleotides slightly increased         Trypanosoma brucei glycoproteins contain novel giant poly-N-acetyllac-
TbGNA1 mutant (Table 2). Intuitively, expect              tosamine carbohydrate chains. J. Biol. Chem. 280:865â€“871.
                                                                     4. Azema, L., et al. 2004. Interaction substituted hexose analogues  lack UDP-GlcNAc reduce rate               Trypanosoma brucei hexose transporter. Biochem. Pharmacol. 67:459â€“467.
UDP-Gal  UDP-Glc precursor) consumption             5. Boehmelt, G., et al. 2000. Cloning characterization murine glu- GPI anchor chain N-glycan processing. rea-             cosamine-6-phosphate acetyltransferase EMeg32. Differential expression
                                                                        intracellular membrane association. J. Biol. Chem. 275:12821â€“12832.
sons anomalous behavior TbUAP mutant              6. Colasante, C., M. Ellis, T. Ruppert, F. Voncken. 2006. Comparative
currently investigation. consequences UDP-                 proteomics glycosomes bloodstream form procyclic culture form
GlcNAc starvation, death 72 h, studied            Trypanosoma brucei brucei. Proteomics 6:3275â€“3293.
                                                                     7. Cross, G.  1996. Antigenic variation trypanosomes: secrets surface
isolating parasites 48 h removal tetracycline.          slowly. Bioessays 18:283â€“291. cells, discrete sets VSG glycoforms corresponding       8. Damerow, S., et al. 2010. Leishmania UDP-sugar pyrophosphorylase. J. Biol.
                                                                        Chem. 285:878â€“887. bands seen SDS-PAGE observed elec-             9. Davis,  J., et al. 2004. Properties GDP-mannose pyrophosphorylase, trospray MS (Fig. 9): set similar wild-type           critical enzyme drug target Leishmania mexicana. J. Biol. Chem.
VSG, lacking higher-molecular-mass             279:12462â€“12468.
                                                                    10. Denton, H., S. Fyffe, T. K. Smith. 2010. GDP-mannose pyrophosphory-
glycoforms, set masses consistent              lase essential bloodstream form Trypanosoma brucei. Biochem. J. absence oligomannose structures C-terminal                425:603â€“614.
 VOL. 10, 2011                                                       T. BRUCEI GLUCOSAMINE 6-PHOSPHATE N-ACETYLTRANSFERASE                                               997

11. Doering, T. L., W. J. Masterson, P. T. Englund, G. W. Hart. 1989.                     stages Leishmania major utilize amino sugars major carbon source.
    Biosynthesis glycosyl phosphatidylinositol membrane anchor                  PLoS Pathog. 6:e1001245.
    trypanosome variant surface glycoprotein: origin non-acetylated glu-         35.   Nagamune, K., et al. 2004. Surface sialic acids taken host allow
    cosamine. J. Biol. Chem. 264:11168â€“11173.                                                 trypanosome survival tsetse fly vectors. J. Exp. Med. 199:1445â€“1450.
12. Emsley, P., B. Lohkamp, W. G. Scott, K. Cowtan. 2010. Features              36.   Nolan, D. P., M. Geuskens, E. Pays. 1999. N-Linked glycans containing
    development Coot. Acta Crystallogr. D Biol. Crystallogr. 66:486â€“501.                   linear poly-N-acetyllactosamine sorting signals endocytosis Trypano-
13. Engstler, M., et al. 2005. membrane-bound histidine acid phosphatase                  soma brucei. Curr. Biol. 9:1169â€“1172.
    TbMBAP1 essential endocytosis membrane recycling Trypano-             37.   Opperdoes, F. R., J. P. Szikora. 2006. silico prediction glyco-
    soma brucei. J. Cell Sci. 118:2105â€“2118.                                                  somal enzymes Leishmania major trypanosomes. Mol. Biochem. Para-
14. Ferguson, M. , M. Duszenko, G. S. Lamont, P. Overath, G.  Cross.                  sitol. 147:193â€“206.
    1986. Biosynthesis Trypanosoma brucei variant surface glycoproteins. N-          38.   Peck, R. F., et al. 2008. LAMP-like protein p67 plays essential role     Glycosylation addition phosphatidylinositol membrane anchor.                     lysosome African trypanosomes. Mol. Microbiol. 68:933â€“946.
    J. Biol. Chem. 261:356â€“362.                                                         39.   Peneff, C., D. Mengin-Lecreulx, Y. Bourne. 2001. crystal structures
15. Freeze, H. H.,  B. Elbein. 2008. Glycosylation precursors, p. 47â€“61.             apo complexed Saccharomyces cerevisiae GNA1 shed light      Varki, R. D. Cummings, J. D. Esko, H. H. Freeze, P. Stanley, C. R.                     catalytic mechanism amino-sugar N-acetyltransferase. J. Biol. Chem.
    Bertozzi, G. W. Hart, M. E. Etzler (ed.). Essentials glycobiology, 2nd             276:16328â€“16334.
    ed. Cold Spring Harbor Laboratory Press, New York, NY.                              40.   Penha, L. L., C. B. Santâ€™Anna, L. Mendonca-Previato, N. L. Cunha-e-Silva,
16. Galland, N., S. Walque, F. G. Voncken, C. L. Verlinde, P.  Michels.              J. O. Previato,  P. Lima. 2009. Sorting phosphoglucomutase     2010. internal sequence targets Trypanosoma brucei triosephosphate                     glycosomes Trypanosoma cruzi mediated internal domain. Glyco-
    isomerase glycosomes. Mol. Biochem. Parasitol. 171:45â€“49.                              biology 19:1462â€“1472.
17. Gao, F., et al. 2006. Synthesis structure-activity relationships trun-       41.   Poux,  N., M. Cebrat, C. M. Kim, P.  Cole, R. Marmorstein. 2002.
    cated bisubstrate inhibitors aminoglycoside 6-N-acetyltransferases.                    Structure GCN5 histone acetyltransferase bound bisubstrate
    J. Med. Chem. 49:5273â€“5281.                                                               inhibitor. Proc. Natl. Acad. Sci. U. S.  99:14065â€“14070.
18. Haanstra, J. R., et al. 2008. Compartmentation prevents lethal turbo-             42.   Roper, J. R., et al. 2005. suppression galactose metabolism procylic
    explosion glycolysis trypanosomes. Proc. Natl. Acad. Sci. U. S.                   form Trypanosoma brucei causes cessation cell growth alters procyclin
    105:17718â€“17723.                                                                          glycoprotein structure copy number. J. Biol. Chem. 280:19728â€“19736.
19. Hinderlich, S., et al. 1998. Purification characterization N-acetylglu-      43.   Roper, J. R., M. L. Guther, K. Milne, M.  Ferguson. 2002. Galactose
 